Business ❯ Healthcare ❯ Pharmaceuticals
Drug Development Phase 3 Trials Regulatory Compliance Drug Efficacy Regulatory Approval Product Compliance Breast Cancer Immunotherapy MariTide Major Depressive Disorder Phase 1 Trial Market Competition COPD Treatment Type 2 Diabetes ADEPT-2 Study Investor Relations VX-993 Cancer Treatments Pemvidutide AI in Healthcare Jasper Therapeutics DESTINY-Breast05 Hyalofast Duchenne Muscular Dystrophy Essential Tremor Cemdisiran Regulatory Approvals AstraZeneca BMS and J&J Blood Thinner Phase 3 Results Investigational Drugs Drug Candidates Social Anxiety Disorder Kidney Disease Amgen RAP-219 Program Product Development Obesity Treatments
Plaintiff firms are recruiting shareholders for lead-plaintiff motions in a Northern District of California case following a steep post-announcement stock drop.
